Table 1 Patients’ characteristics at baseline
N | % | |
|---|---|---|
Total subjects | 31,745 | |
Age (year) | 75.9 ± 14.5 | |
Non-diabetes | 28,720 | 90.5 |
Prediabetes | 1,180 | 4.1 |
DM | 3,025 | 9.5 |
Diabetic retinopathy | 476 | 15.7 |
DN | 1,845 | 61.0% |
DN + hypertension | 1,018 | 55.2 |
DN + coronary heart disease | 432 | 23.4 |
DN + peripheral vascular disease | 766 | 41.5 |
DN with complications | ||
DN + ≤ 2 types of complications | 90 | 4.9 |
DN + 3 types of complications | 875 | 47.4 |
DN + 4 types of complications | 732 | 39.7 |
DN + 5 types of complications | 148 | 8.0 |
Diabetics without nephropathy | 704 | 23.3 |
Medication for DN | 1845 | 100 |
Insulin | 915 | 49.6 |
Glinides | 373 | 20.2 |
α-glucosidase inhibitor | 356 | 19.3 |
Others | 201 | 10.9 |
Medication for prediabetes | 1180 | 100 |
Metformin | 635 | 53.8 |
α-glucosidase inhibitor | 277 | 23.5 |
Thiazolidinedione | 140 | 11.9 |
Others | 128 | 10.8 |